ADRIATIC Trial in Locally Advanced Small-Cell Lung Cancer

0 Views
administrator
administrator
07/07/23

Mark A. Socinski, MD, et al consider the ongoing ADRIATIC trial, which is evaluating the use of concurrent chemoradiotherapy followed by consolidation therapy with durvalumab in locally advanced small-cell lung cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next